← Leaderboards
Yin Ren
Ohio State University
$567,370
Attributed
$567,370
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $191.8K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$567,370 · 1
By mechanism
K08$567,370 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Michael A Caligiuri$65,062,344
- Balveen Kaur$17,543,202
- D Bradley Welling$4,266,843
- Carroll Ann Trotman$11,312,359
- Philip R.o. Payne$8,781,842
Others in their field
Other Rising Stars on “Adhesions”
- John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc.$5,881,537
- Hyunwoo Yuk · Sanaheal, Inc.$4,709,498
- Bozena Korczak · Vascular Vision Pharmaceuticals Company$3,058,782
- Osama Al Dalahmah · Columbia University Health Sciences$2,957,210
- Ming He · University Of California, San Diego$2,917,239
- Todd McFarland · Cerulean Scientific Inc.$2,720,353
Research focus
AdhesionsAdvisory CommitteesAngiogenesisAnimal ModelArchitectureAreaBehaviorBenignBilateral Vestibular SchwannomaBiologicalBiological MarkersBiologyBiomarker IdentificationBrainBrain InjuriesBrain NeoplasmsBrain StemCareerCell LineCell ModelCell MotilityCellsCentral Nervous SystemAcoustic Neuroma
Grant awards (3)
Engineering protease biomarkers to guide surgical therapy for vestibular schwannoma and Neurofibromatosis Type 2$184,001
K08 · FY2025 · DC · contact PI
Engineering protease biomarkers to guide surgical therapy for vestibular schwannoma and Neurofibromatosis Type 2$191,561
K08 · FY2024 · DC · contact PI
Engineering protease biomarkers to guide surgical therapy for vestibular schwannoma and Neurofibromatosis Type 2$191,808
K08 · FY2023 · DC · contact PI